Rectal Speculum segmentation by application delineates three primary demand drivers: Diagnostic, Therapeutic, and Research. The Diagnostic segment encompasses procedures such as proctoscopy, anoscopy, and colorectal cancer screening, accounting for roughly 45 % of total revenue due to high procedure volume in outpatient gastroenterology clinics. The Therapeutic segment includes interventions like hemorrhoid banding, rectal tumor excision, and sphincterotomy, contributing about 35 % of market size; its growth is linked to rising prevalence of anorectal disorders and expanding minimally invasive treatment options. The Research segment, representing approximately 20 % of sales, covers pre‑clinical and clinical studies that require specialized specula for device testing and anatomical investigations. Collectively, these application categories shape the overall market dynamics, with the Diagnostic portion driving the largest absolute sales while the Therapeutic and Research segments provide incremental growth avenues. Accurate Rectal Speculum segmentation is essential for forecasting demand patterns across healthcare settings.